GlassScriptPhysician profile
Nicole Falls
NPI 1982993572
$4,047.27
in general payments reported to CMS, 2019-2025
41 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $232 · 2021: $409 · 2022: $636 · 2023: $378 · 2024: $804 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,101 · Education: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,100.96 |
| Education | $138.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $580.91 | 2019-2025 | |
| Astellas Pharma US INC | $373.34 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $281.80 | 2019-2025 | Aptima, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Fluent Fluid Management System |
| Daiichi Sankyo INC. | $273.14 | 2019-2025 | Injectafer |
| Medtronic, INC. | $217.72 | 2022-2025 | V-Loc 180, Ligasure, Interstim |
| Organon LLC | $171.77 | 2022-2025 | Nexplanon |
| Minerva Surgical, INC | $163.41 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $160.38 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $155.47 | 2021-2025 | |
| Biogen, INC. | $154.01 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $137.43 | 2020-2025 | Slynd |
| Shield Therapeutics INC | $125.13 | 2023-2025 | Accrufer |
| Millicent US INC | $104.08 | 2023-2024 | Intrarosa, Femring |
| Smith+Nephew, INC. | $95.38 | 2019-2025 | Pico, Pico 7 |
| Therapeuticsmd, INC. | $80.08 | 2019-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Falls listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.